Not only the increased TNFα, IL-2, and IL-17 production in CD8 TM cells from GM treated group, we also observed more antigen-specific responders in GM treated RA patients following stimulation with viral peptides. This evidence concerns the gene CD8A and rheumatoid arthritis.